Journal article 1909 views 242 downloads
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme
Andrew Warrilow
,
Josie Parker,
Claire Price
,
W. David Nes,
Edward P. Garvey,
William J. Hoekstra,
Robert J. Schotzinger,
Diane Kelly,
Steven Kelly
Antimicrobial Agents and Chemotherapy, Volume: 60, Issue: 8, Pages: 4530 - 4538
Swansea University Authors:
Andrew Warrilow , Josie Parker, Claire Price
, Diane Kelly, Steven Kelly
-
PDF | Accepted Manuscript
Download (679.82KB)
DOI (Published version): 10.1128/AAC.00349-16
Abstract
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme
| Published in: | Antimicrobial Agents and Chemotherapy |
|---|---|
| Published: |
2016
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa29154 |
| first_indexed |
2016-07-08T12:21:11Z |
|---|---|
| last_indexed |
2020-07-20T12:45:36Z |
| id |
cronfa29154 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-07-20T10:02:18.6746776</datestamp><bib-version>v2</bib-version><id>29154</id><entry>2016-07-08</entry><title>The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme</title><swanseaauthors><author><sid>f066e233e8d0136c9f547b86fa43747f</sid><ORCID>0000-0003-0183-8334</ORCID><firstname>Andrew</firstname><surname>Warrilow</surname><name>Andrew Warrilow</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>e563ed4e1c7db8d1e131fb78a5f8d0d5</sid><firstname>Josie</firstname><surname>Parker</surname><name>Josie Parker</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>9a4e4dfa37f4318c6fa67933d4fc9a17</sid><ORCID>0000-0002-6045-4835</ORCID><firstname>Claire</firstname><surname>Price</surname><name>Claire Price</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5ccf81e5d5beedf32ef8d7c3d7ac6c8c</sid><firstname>Diane</firstname><surname>Kelly</surname><name>Diane Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b17cebaf09b4d737b9378a3581e3de93</sid><firstname>Steven</firstname><surname>Kelly</surname><name>Steven Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-07-08</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Antimicrobial Agents and Chemotherapy</journal><volume>60</volume><journalNumber>8</journalNumber><paginationStart>4530</paginationStart><paginationEnd>4538</paginationEnd><publisher/><keywords/><publishedDay>1</publishedDay><publishedMonth>8</publishedMonth><publishedYear>2016</publishedYear><publishedDate>2016-08-01</publishedDate><doi>10.1128/AAC.00349-16</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-07-20T10:02:18.6746776</lastEdited><Created>2016-07-08T08:29:47.4346544</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Andrew</firstname><surname>Warrilow</surname><orcid>0000-0003-0183-8334</orcid><order>1</order></author><author><firstname>Josie</firstname><surname>Parker</surname><order>2</order></author><author><firstname>Claire</firstname><surname>Price</surname><orcid>0000-0002-6045-4835</orcid><order>3</order></author><author><firstname>W. David</firstname><surname>Nes</surname><order>4</order></author><author><firstname>Edward P.</firstname><surname>Garvey</surname><order>5</order></author><author><firstname>William J.</firstname><surname>Hoekstra</surname><order>6</order></author><author><firstname>Robert J.</firstname><surname>Schotzinger</surname><order>7</order></author><author><firstname>Diane</firstname><surname>Kelly</surname><order>8</order></author><author><firstname>Steven</firstname><surname>Kelly</surname><order>9</order></author></authors><documents><document><filename>0029154-16082017120446.pdf</filename><originalFilename>Viamet_VT1129_Crypto_paper_Open_Access_May2016A.pdf</originalFilename><uploaded>2017-08-16T12:04:46.5370000</uploaded><type>Output</type><contentLength>658841</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2017-08-16T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
| spelling |
2020-07-20T10:02:18.6746776 v2 29154 2016-07-08 The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme f066e233e8d0136c9f547b86fa43747f 0000-0003-0183-8334 Andrew Warrilow Andrew Warrilow true false e563ed4e1c7db8d1e131fb78a5f8d0d5 Josie Parker Josie Parker true false 9a4e4dfa37f4318c6fa67933d4fc9a17 0000-0002-6045-4835 Claire Price Claire Price true false 5ccf81e5d5beedf32ef8d7c3d7ac6c8c Diane Kelly Diane Kelly true false b17cebaf09b4d737b9378a3581e3de93 Steven Kelly Steven Kelly true false 2016-07-08 MEDS Journal Article Antimicrobial Agents and Chemotherapy 60 8 4530 4538 1 8 2016 2016-08-01 10.1128/AAC.00349-16 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2020-07-20T10:02:18.6746776 2016-07-08T08:29:47.4346544 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Andrew Warrilow 0000-0003-0183-8334 1 Josie Parker 2 Claire Price 0000-0002-6045-4835 3 W. David Nes 4 Edward P. Garvey 5 William J. Hoekstra 6 Robert J. Schotzinger 7 Diane Kelly 8 Steven Kelly 9 0029154-16082017120446.pdf Viamet_VT1129_Crypto_paper_Open_Access_May2016A.pdf 2017-08-16T12:04:46.5370000 Output 658841 application/pdf Accepted Manuscript true 2017-08-16T00:00:00.0000000 true eng |
| title |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme |
| spellingShingle |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme Andrew Warrilow Josie Parker Claire Price Diane Kelly Steven Kelly |
| title_short |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme |
| title_full |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme |
| title_fullStr |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme |
| title_full_unstemmed |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme |
| title_sort |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme |
| author_id_str_mv |
f066e233e8d0136c9f547b86fa43747f e563ed4e1c7db8d1e131fb78a5f8d0d5 9a4e4dfa37f4318c6fa67933d4fc9a17 5ccf81e5d5beedf32ef8d7c3d7ac6c8c b17cebaf09b4d737b9378a3581e3de93 |
| author_id_fullname_str_mv |
f066e233e8d0136c9f547b86fa43747f_***_Andrew Warrilow e563ed4e1c7db8d1e131fb78a5f8d0d5_***_Josie Parker 9a4e4dfa37f4318c6fa67933d4fc9a17_***_Claire Price 5ccf81e5d5beedf32ef8d7c3d7ac6c8c_***_Diane Kelly b17cebaf09b4d737b9378a3581e3de93_***_Steven Kelly |
| author |
Andrew Warrilow Josie Parker Claire Price Diane Kelly Steven Kelly |
| author2 |
Andrew Warrilow Josie Parker Claire Price W. David Nes Edward P. Garvey William J. Hoekstra Robert J. Schotzinger Diane Kelly Steven Kelly |
| format |
Journal article |
| container_title |
Antimicrobial Agents and Chemotherapy |
| container_volume |
60 |
| container_issue |
8 |
| container_start_page |
4530 |
| publishDate |
2016 |
| institution |
Swansea University |
| doi_str_mv |
10.1128/AAC.00349-16 |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
1 |
| active_str |
0 |
| published_date |
2016-08-01T03:56:55Z |
| _version_ |
1851092124006612992 |
| score |
11.089572 |

